RNA viruses: Emerging vectors for vaccination and gene therapy

Molecular Medicine Today

Volumn 6, Issue 1, 2000, Pages 28-35

  Hewson, Roger ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ALPHA VIRUS; CLONING VECTOR; GENE THERAPY; GENETIC ENGINEERING; GENETIC MANIPULATION; MEDICAL RESEARCH; NONHUMAN; PICORNAVIRUS; REVIEW; RNA VIRUS; VACCINE PRODUCTION;

ALPHAVIRUS; ANIMALS; FLAVIVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; PICORNAVIRIDAE; REPLICON; RNA VIRUSES; VACCINES, SYNTHETIC;

EID: 0033989821     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(99)01622-6     Document Type: Review

References (31)

1. Baltimore D. Viral RNA dependent DNA polymerase in virions of RNA tumor viuses. Nature. 226:1970;1209-1211.
2. Racaniello V.R., Baltimore D. Cloned poliovirus cDNA is infectious in mammalian cells. Science. 214:1981;916-919.
3. Ahlquist P.et al. Multicomponent RNA plant virus infection derived from cloned viral cDNA. Proc. Natl. Acad. Sci. U. S. A. 81:1984;7066-7070.
4. Ploegh H.L. Viral strategies of immune evasion. Science. 280:1998;248-253.
5. Smith A.E. Viral vectors in gene therapy. Annu. Rev. Microbiol. 49:1995;807-838.
6. Neutra M.R.et al. Epithelial M cells: gateway for mucosal infection and immunity. Cell. 86:1996;345-348.
7. Porter D.C.et al. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Vaccine. 15:1997;257-264.
8. Yim T.J.et al. Poliovirus recombinants expressing Hepatitis B antigens elicited a humoral immune response in susceptible mice. Virology. 218:1996;61-70.
9. Andino R.et al. Engineering poliovirus as a vaccine vector for the expression of diverse antigens. Science. 265:1994;1448-1451.
10. Mandl S.et al. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8216-8221.
11. Doedens J.R., Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J. 14:1995;894-907.
12. Strauss J.H., Strauss E.G. The alphavirus: gene expression, replication and evolution. Microbiol. Rev. 58:1994;491-562.
13. Berglund P.et al. Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Biotechnology. 11:1993;916-920.
14. Smerdou C., Liljestrøm P. Two helper RNA system for production of recombinant Semliki Forest virus. J. Virol. 73:1999;1092-1098.
15. Polo J.M.et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. U. S. A. 96:1999;4598-4603.
16. Pushko P.et al. Replicon-helper systems from attenuated Venezuelan Equine Encephalitis Virus - expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. Virology. 239:1997;389-401.
17. Charles P.C.et al. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate. Virology. 228:1997;153-160.
18. Davis N.L.et al. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge. J. Virol. 70:1996;3781-3787.
19. Agapov E.V.et al. Noncytopathic Sindbis vectors for heterologous gene expression. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12989-12994.
20. Ohno K.et al. Cell-specific targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat. Biotechnol. 15:1998;763-767.
21. Khromykh A.A., Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: Construction and applications. J. Virol. 71:1997;1497-1505.
22. Varnavski A., Khromykh A.A. Noncytopathic flavivirus RNA based system for expression and delivery of heterologous genes. Virology. 255:1999;366-375.
23. Luytjes W.et al. Amplification, expression and packaging of a foreign gene by influenza virus. Cell. 59:1989;1107-1113.
24. Staczek J.et al. A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model. Infec. Immun. 66:1998;3990-3994.
25. Neumann G.et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U. S. A. 96:1999;9345-9350.
26. Schnell M.J.et al. Infectious Rabies virus from cloned cDNA. EMBO J. 13:1994;4195-4203.
27. Conzelmann K.-K. Non-segmented negative strand RNA viruses: genetics and manipulation of viral genomes. Annu. Rev. Genet. 32:1998;123-162.
28. Radecke F.et al. Rescue of Measles virus from cloned DNA. EMBO J. 14:1995;5773-5784.
29. Roberts A.et al. Vaccination with a recombinant Vesicular Stomatitis Virus expressing an influenza virus hemagglutinin provides complete protection from Influenza virus challenge. J. Virol. 72:1998;4704-4711.
30. Mebatsion T.et al. A CXCR4/CD4 pseudotyped rhabdovirus that selectively infects HIV-1 envelope protein expressing cells. Cell. 90:1997;841-847.
31. Schnell M.J.et al. Construction of a novel virus that targets HIV-1 infected cells and controls HIV-1 infection. Cell. 90:1997;847-857.